Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thrive Bioscience Inc.

http://www.thrivebio.com

Latest From Thrive Bioscience Inc.

Harbinger Health CEO Stephen Hahn On Early Cancer Detection To ‘Move The Needle’ On Survival

Medtech Insight spoke with Stephen Hahn, ex-FDA commissioner and CEO of Harbinger Health, who attended SXSW, about the firm’s blood-based cancer test in development.

Exec Chats Cancer

Venture Funding Deals, October 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced August through September 2015.

BioPharmaceutical Medical Device

Emergings In Brief, September 2015

Brief profiles of these recently formed companies: CaveoMed, Checkmate, Metacrine, and Thrive Bioscience.

BioPharmaceutical Medical Device

Out Of The Blocks, September 2015

Brief profiles of these recently formed companies: CaveoMed, Checkmate Pharmaceuticals, Metacrine and Thrive Bioscience.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Laboratory Testing Services
  • Research, Analytical Equipment & Supplies
  • Other Names / Subsidiaries
    • Thrive
UsernamePublicRestriction

Register